More Candidate COVID-19 Vaccines Expected To Enter WHO’s Global Trial

 
• By Ian Schofield

A new global clinical trial initiative is assessing a number of second-generation candidate vaccines for COVID-19. The Australian medicines regulator has given the go-ahead for an approval application for one of the vaccines, from Taiwan’s Medigen.

medigen vaccine
Medigen's COVID-19 vaccine is among the first selected for a global trial platform • Source: Alamy

More from Vaccines

More from Pink Sheet